All In MedTech

Device Trial Radar · NCT03232437

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

A Multicenter Study to Evaluate the External Precision of the Aina HbA1c Monitoring System in Quantitative Measurement of Glycosylated Hemoglobin (HbA1c)

Last checked: Nov 20, 2026Latest source record: Jul 28, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

6

Actual

Start

Jun 14, 2017

Primary completion

Jun 21, 2017

Study completion Jun 21, 2017

Sponsor

Lead sponsor
Jana CareNot on our public-company list
Sponsor type
Industry
Collaborators
The Forsyth Institute; Orange County Research Center; ActivMed Practices & Research
First posted
Jul 28, 2017

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A three site study to evaluate the reproducibility of the Aina HbA1c Monitoring System in quantitative determination of glycosylated hemoglobin (HbA1c) took place at the following sites: 1. Forsyth Institute in Cambridge, MA 2. Orange County Research Center in Tustin, CA 3. ActivMed Practices \& Research in Methuen, MA

Conditions

  • Diabetes

Interventions

  • Aina HbA1c Monitoring SystemDevice

    Monitoring test for quantitative determination of HbA1c

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Precision (as measured by %CV) of HbA1c measurementsTime frame: Each sample was measured in triplicate, twice per day, over the course of five days

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Orange County Research Center

    Tustin, California

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.